Cardinal Health Other Current Assets 2010-2024 | CAH

Cardinal Health other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Cardinal Health other current assets for the quarter ending September 30, 2024 were $0.047B, a INF% increase year-over-year.
  • Cardinal Health other current assets for 2024 were $0.047B, a 66.43% decline from 2023.
  • Cardinal Health other current assets for 2023 were $0.14B, a INF% increase from 2022.
  • Cardinal Health other current assets for 2022 were $0B, a 100% decline from 2021.
Cardinal Health Annual Other Current Assets
(Millions of US $)
2024 $47
2023 $140
2022 $
2021 $1,101
2020 $
2019 $
2018 $756
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $7,189
Cardinal Health Quarterly Other Current Assets
(Millions of US $)
2024-09-30 $47
2024-06-30 $47
2024-03-31 $12
2023-12-31 $12
2023-09-30
2023-06-30 $140
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30 $1,101
2021-03-31 $1,092
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30 $756
2018-03-31
2017-12-31 $2,216
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31 $139
2009-12-31 $149
2009-09-30 $163
2009-06-30 $7,189
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $29.487B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.746B 17.02
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36